Reduced free protein S levels in patients with inflammatory bowel disease: Prevalence, clinical relevance, and role of anti-protein S antibodies

Digestive Diseases and Sciences

Volumn 46, Issue 3, 2001, Pages 637-643

  Saibeni, S ^a   Vecchi, M ^a   Valsecchi, C ^a   Faioni, E M ^a   Razzari, C ^a   De Franchis, R ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Antibodies; Inflammatory bowel disease; Protein S; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY; PROTEIN S;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; THROMBOSIS;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOBLOTTING; INFLAMMATORY BOWEL DISEASES; MALE; PHOSPHOLIPIDS; PROTEIN S;

EID: 0035051403     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005675921664     Document Type: Article

References (36)

1. Venous thrombosis occurring in nonspecific ulcerative colitis: A necropsy study
2. Strokes and ulcerative colitis
3. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis
4. Vascular complications of inflammatory bowel disease
5. Thromboembolism in inflammatory bowel disease: Role of platelets
6. Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis
7. Factor XIIIA subunit and Crohn's disease
8. Thrombotic vascular risk factors in inflammatory bowel disease
9. Evidence for activation of coagulation in Crohn's disease
10. Fibrinolythic split products, fibrinolysis, and factor XIII activity, in inflammatory bowel disease
11. High prevalence of hyperhomocysteienmia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?
12. Transient protein S deficiency associated with cerebral venous thrombosis in active ulcerative colitis
13. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis
14. Portal vein thrombosis and systemic amyloidosis in Crohn's disease-A case report and review of the literature
15. Thrombosis of the renal vein and hemorrhagic rectocolitis
16. Deep venous thrombosis, inflammatory bowel disease and protein S deficiency
17. Free protein S deficiency in patients with Crohn's disease
18. Autoimmune protein S deficiency in a boy with severe thromboembolic disease
19. Postinfectious purpura fulminans caused by an autoantibody directed against protein S
20. Autoimmune protein S deficiency and deep vein thrombosis after chickenpox
21. Protein S deficiency due to a temporary protein S antibody in a young boy with purpura fulminans
22. Chicken-pox and thrombotic complications associated with transient protein C and S deficiencies in children. Seminar on thrombotic complications in neonates and children
23. Autoimmune protein S deficiency
24. Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis
25. Prevalence and significance of anticardiolipin antibodies in Crohn's disease
26. Anticardiolipin antibodies in patients with inflammatory bowel disease
27. Cortisone in ulcerative colitis: Final report of a therapeutic trial
28. Development of a Crohn's disease activity index
29. An abnormal plasma distribution of protein S occurs in functional protein S deficiency
30. Criteria for the diagnosis of lupus anticoagulant: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid antibody of the Scientific and Standardisation Committee of the ISTH
31. The protein C anticoagulant system
32. Free protein S deficiency is a risk factor for venous thrombosis
33. Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect
34. Acquired deficiency of protein S
35. C4b-binding protein a regulatory component of the classical pathway of complement is an acutephase protein is elevated in systemic lupus erythematosus
36. Differential regulation of a and β chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S